Skip to content

Good afternoon · 18 November, Wednesday

11° Cloudy
USD 50.44 ▲0.05 EUR 55.34 ▼0.18 GBP 66.55 ▼0.11 CHF 60.06 ▼0.24
C CNBC · 28 min ago Follow Health

Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.

This story comes from CNBC's feed; the full article and all rights belong to the source.

0

Report / takedown request

Your report is sent to our team and reviewed.

0

Comments (0)

No comments yet. Be the first to comment.

Sign in to write a comment.

Related news